Home › Categories › Consumer Protection

Consumer Protection grants

10 open federal funding opportunities in Consumer Protection, pulled live from Grants.gov and regenerated daily.

Open opportunities

• POOL SAFELY GRANT PROGRAM (PSGP) 2026
  OpenCP-VGB-26-001 · Consumer Product Safety Commission · closes July 13, 2026
• Retail Food Safety Regulatory Association Collaboration
  OpenRFA-FD-26-003 · Food and Drug Administration · closes July 14, 2026
• Minor Use Minor Species Development of Drugs (R01)
  OpenPAR-24-216 · Food and Drug Administration · closes January 29, 2027
• Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
  OpenPAR-25-003 · Food and Drug Administration · closes April 1, 2027
• NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
  OpenPAR-25-014 · Food and Drug Administration · closes April 1, 2027
• Laboratory Flexible Funding Model (LFFM)
  OpenRFA-FD-25-007 · Food and Drug Administration · closes January 11, 2028
• Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
  OpenRFA-FD-25-017 · Food and Drug Administration · closes February 8, 2028
• Animal and Veterinary Innovation Centers (U18)
  OpenPAR-24-251 · Food and Drug Administration · closes May 12, 2028
• Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
  OpenRFA-FD-25-020 · Food and Drug Administration · closes May 16, 2028
• Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
  OpenPAR-23-202 · Food and Drug Administration · closes September 4, 2028

Forecasted

• Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
  ForecastedFOR-FD-25-020 · Food and Drug Administration
• Conformance with the Egg Regulatory Program Standards
  ForecastedFOR-FD-25-021 · Food and Drug Administration
• Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
  ForecastedFOR-FD-25-017 · Food and Drug Administration
• Food Safety Capacity and Infrastructure Building (U2F)
  ForecastedFOR-FD-25-019 · Food and Drug Administration
• FDA's Integrated Food Safety System Training Delivery and Development
  ForecastedFOR-FD-25-016 · Food and Drug Administration
• Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs
  ForecastedFOR-FD-25-022 · Food and Drug Administration
• Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
  ForecastedFOR-FD-25-023 · Food and Drug Administration
• Data Standards for Tobacco Research and Scientific Review Phase 2
  ForecastedFOR-FD-23-027 · Food and Drug Administration
• Center for Research on Complex Generics (U18) Clinical Trials Optional
  ForecastedFOR-FD-25-004 · Food and Drug Administration
• NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
  ForecastedFOR-FD-25-014 · Food and Drug Administration
• REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
  ForecastedFOR-FD-25-012 · Food and Drug Administration
• Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
  ForecastedFOR-FD-24-007 · Food and Drug Administration
• FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
  ForecastedFOR-FD-24-016 · Food and Drug Administration
• Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
  ForecastedFOR-FD-24-005 · Food and Drug Administration
• Minor Use Minor Species Development of Drugs (R01)
  ForecastedFOR-FD-24-013 · Food and Drug Administration
• Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
  ForecastedFOR-FD-24-004 · Food and Drug Administration
• Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
  ForecastedFOR-FD-25-015 · Food and Drug Administration
• Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
  ForecastedFOR-FD-25-013 · Food and Drug Administration
• OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
  ForecastedFOR-FD-24-017 · Food and Drug Administration
• Manufactured Foods Flexible Funding Model (MF-FFM)
  ForecastedFOR-FD-23-014 · Food and Drug Administration
• Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
  ForecastedFOR-FD-24-008 · Food and Drug Administration
• Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
  ForecastedFOR-FD-25-009 · Food and Drug Administration
• Retail Food Safety Regulatory Association Collaboration CAP
  ForecastedFOR-FD-25-008 · Food and Drug Administration
• Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
  ForecastedFOR-FD-25-001 · Food and Drug Administration
• Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
  ForecastedFOR-FD-24-015 · Food and Drug Administration
• Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
  ForecastedFOR-FD-24-010 · Food and Drug Administration
• Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
  ForecastedFOR-FD-25-003 · Food and Drug Administration
• Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
  ForecastedFOR-FD-24-003 · Food and Drug Administration
• Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
  ForecastedFOR-FD-25-011 · Food and Drug Administration
• Animal Food Regulatory Program Alliance
  ForecastedFOR-FD-25-002 · Food and Drug Administration
• Studies Addressing Rare Neurodegenerative Diseases including ALS
  ForecastedFOR-FD-25-006 · Food and Drug Administration
• Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed
  ForecastedFOR-FD-24-006 · Food and Drug Administration
• Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines
  ForecastedFOR-FD-25-010 · Food and Drug Administration
• Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
  ForecastedFOR-FD-24-009 · Food and Drug Administration
• Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center
  ForecastedFOR-FD-25-005 · Food and Drug Administration
• Collaborations to Enhance Drug Development and Regulatory Science
  ForecastedFOR-FD-24-014 · Food and Drug Administration
• Rapid Response Team (RRT) Cooperative Agreement
  ForecastedFOR-FD-23-016 · Food and Drug Administration
• Critical Path Public Private Partnerships Clinical Trials Optional
  ForecastedFOR-FD-24-012 · Food and Drug Administration
• Retail Food Safety Regulatory Association Collaboration
  ForecastedFOR-FD-26-003 · Food and Drug Administration
• Novel approaches to support therapeutic development in ultra-rare cancers
  ForecastedFOR-FD-26-004 · Food and Drug Administration